| 1 |
33314130 | A newly devised flow cytometric antibody binding assay helps evaluation of dithiothreitol treatment for the inactivation of CD38 on red blood cells. | 2021 Jul |
4 |
| 2 |
32530397 | New method for overcoming the interference produced by anti-CD38 monoclonal antibodies in compatibility testing. | 2020 Jul |
1 |
| 3 |
32632934 | Daudi cell stroma: An alternative to dithiothreitol to resolve daratumumab interference in pretransfusion testing. | 2020 Sep |
2 |
| 4 |
31466605 | Impact of Novel Monoclonal Antibody Therapeutics on Blood Bank Pretransfusion Testing. | 2019 Oct |
2 |
| 5 |
31933572 | Daratumumab Interference in Pretransfusion Testing Is Overcome by Addition of Daratumumab Fab Fragments to Patients' Plasma. | 2019 Dec |
1 |
| 6 |
29519368 | Transfusion management for patients taking an anti-CD38 monoclonal antibody. | 2018 Jan - Mar |
4 |
| 7 |
30267414 | Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method). | 2018 Dec |
2 |
| 8 |
29378150 | Dithiothreitol treatment of red blood cells. | 2017 Dec |
2 |
| 9 |
25764134 | Resolving the daratumumab interference with blood compatibility testing. | 2015 Jun |
2 |
| 10 |
10699577 | Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers. | 2000 Mar 6 |
1 |
| 11 |
7775378 | Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen. | 1995 Jan |
1 |
| 12 |
8394323 | NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. | 1993 Aug 15 |
2 |